Javascript must be enabled to continue!
Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
View through CrossRef
Pneumococcal disease is a major contributor to global childhood morbidity and mortality and is more common in low- and middle-income countries (LMICs) than in high-income countries. Pneumococcal carriage is a prerequisite for pneumococcal disease. Pneumococcal conjugate vaccine reduces vaccine-type carriage and disease. However, pneumococcal carriage and disease persist, and it is important to identify other potentially modifiable factors associated with pneumococcal carriage and determine if risk factors differ between low, middle, and high-income countries. This information may help inform pneumococcal disease prevention programs. This systematic literature review describes factors associated with pneumococcal carriage stratified by country income status and summarises pneumococcal carriage rates for included studies. We undertook a systematic search of English-language pneumococcal nasopharyngeal carriage studies up to 30thJune 2021. Peer-reviewed studies reporting factors associated with overall pneumococcal nasopharyngeal carriage in healthy, community-based study populations were eligible for inclusion. Two researchers independently reviewed studies to determine eligibility. Results are presented as narrative summaries. This review is registered with PROSPERO, CRD42020186914. Eighty-two studies were included, and 46 (56%) were conducted in LMICs. There was heterogeneity in the factors assessed in each study. Factors positively associated with pneumococcal carriage in all income classification were young age, ethnicity, symptoms of respiratory tract infection, childcare attendance, living with young children, poverty, exposure to smoke, season, and co-colonisation with other pathogens. Breastfeeding and antibiotic use were protective against carriage in all income classifications. Median (interquartile range) pneumococcal carriage rates differed by income classification, ranging from 51% (19.3–70.2%), 38.5% (19.3–51.6%), 31.5% (19.0–51.0%), 28.5% (16.8–35.4%), (P= 0.005) in low-, lower-middle, upper-middle, and high-income classifications, respectively. Our findings suggest that where measured, factors associated with pneumococcal nasopharyngeal carriage are similar across income classifications, despite the highest pneumococcal carriage rates being in low-income classifications. Reducing viral transmission through vaccination and public health interventions to address social determinants of health would play an important role.
Public Library of Science (PLoS)
Title: Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
Description:
Pneumococcal disease is a major contributor to global childhood morbidity and mortality and is more common in low- and middle-income countries (LMICs) than in high-income countries.
Pneumococcal carriage is a prerequisite for pneumococcal disease.
Pneumococcal conjugate vaccine reduces vaccine-type carriage and disease.
However, pneumococcal carriage and disease persist, and it is important to identify other potentially modifiable factors associated with pneumococcal carriage and determine if risk factors differ between low, middle, and high-income countries.
This information may help inform pneumococcal disease prevention programs.
This systematic literature review describes factors associated with pneumococcal carriage stratified by country income status and summarises pneumococcal carriage rates for included studies.
We undertook a systematic search of English-language pneumococcal nasopharyngeal carriage studies up to 30thJune 2021.
Peer-reviewed studies reporting factors associated with overall pneumococcal nasopharyngeal carriage in healthy, community-based study populations were eligible for inclusion.
Two researchers independently reviewed studies to determine eligibility.
Results are presented as narrative summaries.
This review is registered with PROSPERO, CRD42020186914.
Eighty-two studies were included, and 46 (56%) were conducted in LMICs.
There was heterogeneity in the factors assessed in each study.
Factors positively associated with pneumococcal carriage in all income classification were young age, ethnicity, symptoms of respiratory tract infection, childcare attendance, living with young children, poverty, exposure to smoke, season, and co-colonisation with other pathogens.
Breastfeeding and antibiotic use were protective against carriage in all income classifications.
Median (interquartile range) pneumococcal carriage rates differed by income classification, ranging from 51% (19.
3–70.
2%), 38.
5% (19.
3–51.
6%), 31.
5% (19.
0–51.
0%), 28.
5% (16.
8–35.
4%), (P= 0.
005) in low-, lower-middle, upper-middle, and high-income classifications, respectively.
Our findings suggest that where measured, factors associated with pneumococcal nasopharyngeal carriage are similar across income classifications, despite the highest pneumococcal carriage rates being in low-income classifications.
Reducing viral transmission through vaccination and public health interventions to address social determinants of health would play an important role.
Related Results
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
Abstract
Background
Pneumococcal disease is a major contributor to global childhood morbidity and mortality. Pneumococcal carria...
Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration
Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration
Abstract
Streptococcus pneumoniae
is a leading cause of invasive disease in infants, especially in low-income settings. Asympto...
Pneumococcal Serotypes in Urban Ugandan Children Vaccinated with the 10-Valent Pneumococcal Conjugate Vaccine
Pneumococcal Serotypes in Urban Ugandan Children Vaccinated with the 10-Valent Pneumococcal Conjugate Vaccine
Abstract
Objective
Uganda introduced the 10-valent pneumococcal conjugate vaccine (PCV10) into routine infant immunization in 2014, but post-int...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Background: In the Democratic Republic of Congo (DRC), the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in 2011 through a three-dose schedule, targeting infants ...
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
Review question / Objective: Clinical trials for young patients with nasopharyngeal carcinoma are very limited. because of the rarity of nasopharyngeal carcinoma in young patients,...
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Introduction
In Canada, pneumococcal vaccination is recommended to all adults aged ≥65 and those <65 who have one or more chronic medical conditions (CMCs). Understanding vaccin...
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
AbstractBackground. Although it is widely accepted that adults with immunocompromising conditions are at greatly increased risk of pneumococcal infection, the extent of risk among...

